Clinical Trial Update: Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate electroacupuncture plus a 5-HT3 receptor inhibitor for preventing postoperative nausea and vomiting in high-risk pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• 5-HT3 receptor inhibitor

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: PONV | NA | Status: RECRUITING